Clinical Trials And Specific Jurisdiction After Bristol-Myers
By Matthew Saxon and Rand Brothers ( October 22, 2019, 4:31 PM EDT) -- What clinical activities are sufficient to establish specific jurisdiction over drug and medical device manufacturers? In the wake of the U.S. Supreme Court's decision in Bristol-Myers Squibb Co. v. Superior Court of California,[1] this has become an increasingly important question that can determine where a company is forced to litigate....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.